IGC Pharma Inc (IGC)

Mar 12, 2025

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25" - ACCESS Newswire

Mar 12, 2025

Mar 12, 2025

IGC Pharma Catches Analyst Attention: $4.25 Target Set as Clinical Milestones Approach - StockTitan

Mar 12, 2025

Mar 10, 2025

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results" - ACCESS Newswire

Mar 10, 2025

Mar 10, 2025

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the “Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results” - StockTitan

Mar 10, 2025

Mar 06, 2025

IGC Pharma, Inc. (IGC) Advances AI Model to Enhance Alzheimer’s Diagnosis - Insider Monkey

Mar 06, 2025

Mar 05, 2025

12 AI Stocks Making Headlines: Latest News and Ratings - Insider Monkey

Mar 05, 2025

Mar 04, 2025

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia Detection - Big News Network

Mar 04, 2025

Mar 04, 2025

Can This New AI Tool Revolutionize How Doctors Diagnose Alzheimer's Disease? - StockTitan

Mar 04, 2025

Feb 25, 2025

Ascendiant Capital Markets Issues Positive Forecast for IGC Pharma (NYSEMKT:IGC) Stock Price - Defense World

Feb 25, 2025

Feb 21, 2025

IGC Pharma expands Holiby line with ‘Longevity’, ‘Renew’ - Yahoo Finance

Feb 21, 2025

Feb 21, 2025

IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and - GuruFocus.com

Feb 21, 2025

Feb 20, 2025

IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew'Targeting the Multi-Billion-Dollar Anti-Aging Market - Newswire

Feb 20, 2025

Feb 18, 2025

IGC Pharma's Earnings Show Major Turnaround: Net Loss Shrinks 69% While Alzheimer's Drug Shows Promise - StockTitan

Feb 18, 2025

Feb 18, 2025

IGC Pharma Reports Third Quarter Fiscal 2025 Results - ACCESS Newswire

Feb 18, 2025

Feb 15, 2025

IGC Pharma, Inc. (IGC) Reports Q3 Loss, Tops Revenue Estimates - MSN

Feb 15, 2025

Feb 14, 2025

IGC Pharma Inc. (IGC) reports earnings - Quartz

Feb 14, 2025

Feb 13, 2025

Page 3 | IGC PHARMA INC. DL -,01 Trade Ideas — FWB:IGS1 - TradingView

Feb 13, 2025

Feb 11, 2025

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM) - StreetInsider.com

Feb 11, 2025

Feb 11, 2025

IGC Pharma launches Holiby wellness brand - TipRanks

Feb 11, 2025

Feb 11, 2025

IGC Pharma, Inc.: IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby - finanznachrichten.de

Feb 11, 2025

Feb 11, 2025

IGC Pharma's Strategic Pivot: New Wellness Brand Holiby™ Taps Into Booming $75B Gummies Market - StockTitan

Feb 11, 2025

Feb 06, 2025

Market Recap: IGC Pharma Inc (IGC)’s Positive Momentum, Closing at 0.32 - The Dwinnex

Feb 06, 2025

Feb 04, 2025

Alzheimer’s Clinical Trials News Roundup: Q4 - Being Patient

Feb 04, 2025

Feb 03, 2025

Page 3 | IGC PHARMA INC Trade Ideas — TRADEGATE:IGS1 - TradingView

Feb 03, 2025

Feb 01, 2025

IGC Pharma, Inc. (IGC) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN

Feb 01, 2025

Jan 30, 2025

IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease - Joplin Globe

Jan 30, 2025

Jan 28, 2025

Revolutionary Voice AI Could Detect Alzheimer's Before Symptoms ShowIGC's Breakthrough - StockTitan

Jan 28, 2025

Jan 27, 2025

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1 - ACCESS Newswire

Jan 27, 2025

Jan 27, 2025

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline - ACCESS Newswire

Jan 27, 2025

Jan 25, 2025

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy - ACCESS Newswire

Jan 25, 2025

Jan 24, 2025

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025 - ACCESS Newswire

Jan 24, 2025

Jan 24, 2025

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies - ACCESS Newswire

Jan 24, 2025

Jan 24, 2025

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge - ACCESS Newswire

Jan 24, 2025

Jan 23, 2025

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets - ACCESS Newswire

Jan 23, 2025

Jan 22, 2025

IGC Pharma Appoints Former Virginia Governor Terry McAuliffe as Strategic Advisor - Markets Insider

Jan 22, 2025

Jan 14, 2025

Geode Capital Management LLC Has $240,000 Stock Holdings in IGC Pharma, Inc. (NYSEMKT:IGC) - Defense World

Jan 14, 2025

Jan 13, 2025

IGC Pharma to Unveil Alzheimer's Pipeline and AI Drug Discovery Updates at Investor Chat - StockTitan

Jan 13, 2025

Jan 08, 2025

Amazon To Sell Ad Tools To Third Parties - Baystreet.ca

Jan 08, 2025

Jan 08, 2025

IGC Gains on Word of Alzheimer’s Treatment - Baystreet.ca

Jan 08, 2025